title: Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
abstract: Thirty-eight children with acute lymphoblastic leukaemia were treated with the BFM regimen. Thirty-six (94.7%) achieved complete remission (CR). Twenty 58.8%) of 34 evaluable patients are in continuous complete remission (CCR) at a median follow-up of 33 (range 19-81) months. Long-term disease-free survival was better in the 2-9 years age group (83%) when compared to the 10-14 years group (43%) (P < .05).
authors.affiliation: Department of Haematology, Christian Medical College and Hospital, Tamil Nadu, India.
authors.forename: G C
authors.initials: GC
authors.lastname: Kudva
authors.forename: M
authors.initials: M
authors.lastname: Chandy
authors.forename: P
authors.initials: P
authors.lastname: Raghupathy
authors.forename: D
authors.initials: D
authors.lastname: Dennison
authors.forename: A
authors.initials: A
authors.lastname: Srivastava
authors.forename: V
authors.initials: V
authors.lastname: Bhushan
authors.forename: R
authors.initials: R
authors.lastname: Singh
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D016896:Treatment Outcome